Heart transplantation and chronic lymphocytic leukemia: A successful case at 2 years of follow-up

被引:0
|
作者
Manito, N [1 ]
Kaplinsky, E [1 ]
Roca, J [1 ]
de Sevilla, AF [1 ]
Castells, E [1 ]
Esplugas, E [1 ]
机构
[1] Univ Barcelona, Bellvitge Hosp, Heart Transplant Unit, Hosp Llobregat, Barcelona 08907, Spain
来源
关键词
D O I
10.1016/j.healun.2003.07.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In June 2000, we successfully performed an orthotopic cardiac transplant in a 52-year-old man who, together with a B-cell chronic lymphocytic leukemia (Binet Stage A, Rai Stage 1), also had end-stage dilated idiopathic myocardiopathy. We describe his case and the 2 years of cancer-free follow-up. To our knowledge, this is the first report of a heart transplant in this setting.
引用
收藏
页码:777 / 779
页数:3
相关论文
共 50 条
  • [41] EFFICACY OF FC AND FCR REGIMENS IN THE FIRST LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: 7,5 YEARS OF FOLLOW-UP
    D'Auria, F.
    Guariglia, R.
    Villani, O.
    Pietrantuono, G.
    Martorelli, M.
    Mansuerto, G.
    Grieco, V.
    Zonno, A.
    Zifarone, E.
    Bianchino, G.
    Di Giovannantonio, L.
    Vita, G.
    Musto, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 331 - 332
  • [42] Acalabrutinib vs rituximab plus idelalisib or bendamustine in relapsed/refractory chronic lymphocytic leukemia: ASCEND results at ∼4 years of follow-up
    Welslau, M.
    Jurczak, W.
    Pluta, A.
    Wach, M.
    Lysak, D.
    Simkovic, M.
    Kriachok, I
    Illes, A.
    De la Serna, J.
    Dolan, S.
    Campbell, P.
    Musuraca, G.
    Jacob, A.
    Avery, E. J.
    Hoon, Lee J.
    Usenko, G.
    Wang, M. H.
    Yu, T.
    Ghia, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 118 - 119
  • [43] EEF FOLLOW-UP OF 2 YEARS OF A CASE OF MIDLINE TUMOR
    FREY, Z
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1977, 42 (06): : 855 - 855
  • [44] PULMONARY-FUNCTION AFTER SUCCESSFUL HEART-TRANSPLANTATION - ONE YEAR FOLLOW-UP
    RAVENSCRAFT, SA
    GROSS, CR
    KUBO, SH
    OLIVARI, MT
    SHUMWAY, SJ
    BOLMAN, RM
    HERTZ, MI
    CHEST, 1993, 103 (01) : 54 - 58
  • [45] ALLOTRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKAEMIA A FOLLOW-UP OF 12 PATIENTS
    Holowiecki, J. H.
    Krawczyk-Kulis, M.
    Stella-Holowiecka, B.
    Czerw, T.
    Wojnar, J.
    Markiewicz, M.
    Giebel, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 493 - 493
  • [46] Transplantation in chronic lymphocytic leukemia
    Le Dieu R.
    Gribben J.G.
    Current Hematologic Malignancy Reports, 2007, 2 (1) : 56 - 63
  • [47] Acalabrutinib with obinutuzumab in treatmentnaive and relapsed/refractory chronic lymphocytic leukemia: 3-year follow-up
    Woyach, Jennifer
    Rogers, Kerry
    Bhat, Seema
    Blachly, James
    Jianfar, Mojgan
    Frigault, Melanie M.
    Hamdy, Ahmed
    Izumi, Raquel
    Munugalavadla, Veerendra
    Quah, Cheng
    Wang, Min Hui
    Byrd, John C.
    LEUKEMIA & LYMPHOMA, 2020, 61 : 17 - 18
  • [48] Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemia
    Zinzani, PL
    Bendandi, M
    Magagnoli, M
    Albertini, P
    Rondelli, D
    Stefoni, V
    Tani, M
    Tura, S
    HAEMATOLOGICA, 2000, 85 (11) : 1135 - 1139
  • [49] It is feasible and safe to stop specialized follow-up of asymptomatic lower-risk chronic lymphocytic leukemia
    Brieghel, Christian
    da Cunha-Bang, Caspar
    Mourek, Jindrich
    Kjeldsen, Lars
    Niemann, Carsten U.
    BLOOD ADVANCES, 2024, 8 (16) : 4449 - 4456
  • [50] EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia
    Eichhorst, Barbara
    Ghia, Paolo
    HEMASPHERE, 2021, 5 (01):